Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may flag heart danger before carotid surgery

NCT ID NCT05293067

Knowledge-focused Sponsor: University of Belgrade Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial investigates whether measuring high-sensitive troponin, a protein released during heart injury, can predict heart complications in people undergoing surgery to open a narrowed carotid artery. About 527 participants will have their troponin levels checked before and after the procedure. The goal is to see if this test can help doctors decide who is at higher risk and whether routine testing should be standard.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
high-sensitive troponin test
What this could lead to
If successful, this could help doctors identify which patients are at higher risk of heart problems after carotid surgery, potentially guiding safer treatment decisions.
What could go wrong
This is an observational study, not a treatment trial. It may not prove that troponin testing improves outcomes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

527 people

The number who actually took part.

Started

Jun 2023

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with extracranial carotid stenosis greater than 50% (NASCET) in the carotid bifurcation or internal carotid artery assessed by ultrasound in whom carotid revascularisation is planned;

Ages

40 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Extracranial carotid stenosis greater than 50% (NASCET) in the carotid bifurcation or internal carotid artery assessed by ultrasound in whom carotid revascularisation is planned; * The ability of the patient for follow-up examinations; * Personally signed informed consent Exclusion Criteria: * Patients admitted due to emergency procedure for immediate surgical treatment (the same day); * Patients with preoperative anemia (due to any reason, hemoglobin level \< 10 g/dL); * Patients in whom concomitant or "staged" cardiac surgery or vascular procedure is planned, * Patients who had an acute coronary event in the previous 3 months; * Patients undergoing multiple CEA/CAS during the study period; * Patients with end-stage kidney disease; * Patients with sepsis: * Patients with acute pericarditis/myocarditis; * Patients with advanced heart failure; * Patients on chemotherapy, * Patients with systemic inflammatory diseases; * Patients with critical limb ischemia;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carotid artery stenosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

carotid stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carotid artery stenosis

Contacts and locations

Locations

  • Clinic for Vascular and Endovascular Surgery, University Clinical Center of Serbia

    Belgrade, Serbia, 11000, Serbia

More trials for these conditions

Other studies related to the condition(s) this trial covers.